VIDAS? LYME IGG 30320

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,u report with the FDA on 2016-08-30 for VIDAS? LYME IGG 30320 manufactured by Biomerieux Sa.

Event Text Entries

[53554043] A customer reported to biomerieux a discrepant result event occurred when using the vidas lyme igg test kit. The customer reported that the vidas lyme igg test kit returned a negative result for a patient sample whereas a western blot on the same sample returned a positive result. When specifically asked, the customer indicated no adverse impact to the patient or delay in results was experienced as a result of this event. An investigation has been initiated by biomerieux to investigate this event.
Patient Sequence No: 1, Text Type: D, B5


[58088660] An investigation into a discrepant result event while using the vidas? Lyme igg test kit was performed. The customer obtained a negative result with the vidas? Lyme igg test kit yet the western blot was positive. An analysis of the batch history records shows no anomaly during the control process. Quality control samples near the cut off of the vidas? Lyme igg test kit were performed on retain samples of the lot in question. All samples returned the expected results. The performance of the lot in question has not changed since original release to the field. Testing of the return patient sample on retain samples from the lot in question as well as another lot was also performed. Both lots returned a negative result consistent with the customer's result. The quality product laboratory has tested the return sample on the retain kit vidas? Lyme igg 1004526300 / 161123-0 and on a other retain kit vidas? Lyme igg 1004350980 / 160914-0. A third technique was utilized in conjunction with the returned patient sample, alldiag optimacheck lyme assay (immunoblot). The customer's return sample was tested and gave negative results for both igg and igm. The negative results obtained with the alldiag optimacheck lyme assay (immunoblot) were in agreement with the vidas? Technique. The most likely root cause is that the euroimmun technique has a higher sensitivity than the alldiag technique and vidas? Lyme igg as tested in our laboratory. Moreover as the patient was treated, the decrease of antibodies with negative igm and a low level of igg shows that the treatment is effective. Based on the results of this investigation, the product is performing in accordance with the limitations of the method.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number3002769706-2016-00160
MDR Report Key5914936
Report SourceFOREIGN,HEALTH PROFESSIONAL,U
Date Received2016-08-30
Date of Report2016-08-05
Date Mfgr Received2016-08-05
Date Added to Maude2016-08-30
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMRS. ELLEN WELTMER
Manufacturer Street595 ANGLUM ROAD
Manufacturer CityHAZELWOOD MO 63042
Manufacturer CountryUS
Manufacturer Postal63042
Manufacturer Phone3147317301
Manufacturer G1BIOMERIEUX SA
Manufacturer StreetCHEMIN DE L ORME
Manufacturer CityMARCY L ETOILE, RHONE 69280
Manufacturer CountryFR
Manufacturer Postal Code69280
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameVIDAS? LYME IGG
Generic NameVIDAS? LYME IGG
Product CodeLSR
Date Received2016-08-30
Catalog Number30320
Lot Number1004526300
Device Expiration Date2016-11-23
OperatorHEALTH PROFESSIONAL
Device Availability*
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerBIOMERIEUX SA
Manufacturer AddressCHEMIN DE L ORME MARCY L ETOILE, RHONE 69280 FR 69280


Patients

Patient NumberTreatmentOutcomeDate
10 2016-08-30

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.